Solesence (NASDAQ:SLSN – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.01) EPS for the quarter, FiscalAI reports. Solesence had a return on equity of 10.50% and a net margin of 2.88%.The company had revenue of $12.96 million for the quarter.
Solesence Price Performance
Solesence stock opened at $1.24 on Wednesday. Solesence has a 52 week low of $0.78 and a 52 week high of $5.63. The company has a quick ratio of 0.74, a current ratio of 2.07 and a debt-to-equity ratio of 0.60. The firm’s 50-day simple moving average is $1.13 and its 200 day simple moving average is $1.65. The firm has a market capitalization of $87.58 million, a PE ratio of 62.03 and a beta of 1.30.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Solesence in a research report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Solesence has a consensus rating of “Sell”.
Hedge Funds Weigh In On Solesence
Hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE bought a new stake in Solesence in the second quarter worth approximately $26,000. JPMorgan Chase & Co. bought a new stake in Solesence during the second quarter worth approximately $39,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Solesence during the second quarter valued at approximately $45,000. Goldman Sachs Group Inc. acquired a new position in Solesence during the fourth quarter valued at approximately $30,000. Finally, New York State Common Retirement Fund bought a new position in shares of Solesence in the second quarter valued at approximately $95,000. Institutional investors and hedge funds own 70.22% of the company’s stock.
About Solesence
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.
Recommended Stories
- Five stocks we like better than Solesence
- Why OpenAI’s IPO Plans Could Be a Massive Win for Microsoft
- A Real Biggie Deal: Wendy’s Serves Up a Juicy Buyout Arbitrage
- Ally Financial Is Back to Basics—And Investors Are Watching
- Navitas Breaks Out on India Deal, Validating High-Power AI Pivot
Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.
